A rebound driven by the convergence of favorable supply contract news and an oversold phase, with an upside stronger than expected

Reviewing Prediction vs. Actual Result

To state the conclusion first, the prediction based on the support level near the 20-day low and the oversold condition with an RSI of 19.9 proved to be correct, and coupled with the CSL supply contract update news, the actual outcome resulted in an OVERHIT judgment with a 17.5% return. At the time, we anticipated that the extreme oversold indicator of an RSI of 19.9 and the price level near the 20-day low support line ($100.53) would create downward rigidity, and indeed, this support line held, allowing short-term rebound attempts to work effectively. However, the fact that it exceeded the expected take-profit target ($110.45) to record a larger gain (17.5%) demonstrates that the ripple effect of the positive news, aligned with the increasing trend in thematic news (healthcare theme up to 56 articles in the last 7 days, rising), strongly broke through the short-term resistance line.

What to Watch in the Next Analysis

Incorporating this review into future trades, I should remember that the intersection of an extreme oversold zone (RSI 19.9) and a major support line ($100.53) not only indicates a high probability of a rebound, but also creates significant upside potential when accompanied by positive catalysts. Moving forward, in phases where both technical oversold signals and thematic momentum (an upward trend) are simultaneously detected, I will keep the possibility of further momentum expansion open after reaching the set take-profit price and apply flexible response strategies such as scaled profit-taking.